日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CORRIGENDUM: Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1

更正:用于治疗克里格勒-纳贾尔综合征1型的编码UGT1A1酶的hUGT1A1-modRNA的定量系统药理学模型

Apgar, J F; Tang, J P; Singh, P; Balasubramanian, N; Burke, J M; Hodges, M R; Lasaro, M A; Lin, L; Millard, B L; Moore, K; Jun, L S; Sobolov, S; Wilkins, A K; Gao, X

Systemic Alanine Glyoxylate Aminotransferase mRNA Improves Glyoxylate Metabolism in a Mouse Model of Primary Hyperoxaluria Type 1

系统性丙氨酸乙醛酸氨基转移酶 mRNA 可改善原发性高草酸尿症 1 型小鼠模型中的乙醛酸代谢

Anjli Kukreja, Melissa Lasaro, Christian Cobaugh, Chris Forbes, Jian-Ping Tang, Xiang Gao, Cristina Martin-Higueras, Angel L Pey, Eduardo Salido, Susan Sobolov, Romesh R Subramanian

Genetic variant in CXCL12 gene raises susceptibility to HPV infection and squamous intraepithelial lesions development: a case-control study

CXCL12 基因遗传变异增加 HPV 感染和鳞状上皮内病变发展的易感性:一项病例对照研究

Nádia Calvo Martins Okuyama, Fernando Cezar-Dos-Santos, Érica Romão Pereira, Kleber Paiva Trugilo, Guilherme Cesar Martelossi Cebinelli, Michelle Mota Sena, Ana Paula Lombardi Pereira, Adriano Martin Felis Aranome, Luis Fernando Lasaro Mangieri, Rodolfo Sanches Ferreira, Maria Angelica Ehara Watanab

Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1

编码 UGT1A1 酶的 hUGT1A1-modRNA 的定量系统药理学模型用于治疗 1 型克里格勒-纳贾尔综合征

Apgar, Joshua F; Tang, Jian-Ping; Singh, Pratap; Balasubramanian, Nanda; Burke, John; Hodges, Michael R; Lasaro, Melissa A; Lin, Lin; Millard, Bjorn L; Moore, Kristi; Jun, Lucy S; Sobolov, Susan; Wilkins, Anna Katharina; Gao, Xiang

Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action

ALXN1210 的设计和临床前表征:一种具有延长作用时间的新型抗 C5 抗体

Douglas Sheridan, Zhao-Xue Yu, Yuchun Zhang, Rekha Patel, Fang Sun, Melissa A Lasaro, Keith Bouchard, Bruce Andrien, Andre Marozsan, Yi Wang, Paul Tamburini

Maximizing in vivo target clearance by design of pH-dependent target binding antibodies with altered affinity to FcRn

通过设计对FcRn具有不同亲和力的pH依赖性靶点结合抗体,最大限度地提高体内靶点清除率。

Danlin Yang,Craig Giragossian,Steven Castellano,Marcio Lasaro,Haiguang Xiao,Himanshu Saraf,Cynthia Hess Kenny,Irina Rybina,Zhong-Fu Huang,Jennifer Ahlberg,Tammy Bigwarfe,Maria Myzithras,Erica Waltz,Simon Roberts,Rachel Kroe-Barrett,Sanjaya Singh

Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy

靶向补体抑制治疗实验性C3肾小球病的疗效

Ruseva, Marieta M; Peng, Tao; Lasaro, Melissa A; Bouchard, Keith; Liu-Chen, Susan; Sun, Fang; Yu, Zhao-Xue; Marozsan, Andre; Wang, Yi; Pickering, Matthew C

Efficient Qualitative and Quantitative Determination of Antigen-induced Immune Responses

高效定性和定量测定抗原诱导的免疫反应

Danlin Yang, Lee Frego, Marcio Lasaro, Kristopher Truncali, Rachel Kroe-Barrett, Sanjaya Singh

GENOTYPE CHARACTERIZATION OF Leishmania (Viannia) braziliensis ISOLATED FROM HUMAN AND CANINE BIOPSIES WITH AMERICAN CUTANEOUS LEISHMANIASIS

从患有美洲皮肤利什曼病的人类和犬类活检样本中分离出的巴西利什曼原虫(Leishmania (Viannia) braziliensis)的基因型特征分析

Ferreira, Lasaro Teixeira; Gomes, Aparecida Helena de Souza; Pereira-Chioccola, Vera Lucia

Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents

含有间日疟原虫环子孢子蛋白的初免-加强疫苗在啮齿动物中的免疫原性

Teixeira, Lais H; Tararam, Cibele A; Lasaro, Marcio O; Camacho, Ariane G A; Ersching, Jonatan; Leal, Monica T; Herrera, Sócrates; Bruna-Romero, Oscar; Soares, Irene S; Nussenzweig, Ruth S; Ertl, Hildegund C J; Nussenzweig, Victor; Rodrigues, Mauricio M